Pharming (PHAR) Gross Profit (2020 - 2025)
Historic Gross Profit for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to $19.4 million.
- Pharming's Gross Profit fell 7141.7% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $325.7 million, marking a year-over-year increase of 761.73%. This contributed to the annual value of $261.8 million for FY2024, which is 1894.42% up from last year.
- According to the latest figures from Q3 2025, Pharming's Gross Profit is $19.4 million, which was down 7141.7% from $155.0 million recorded in Q2 2025.
- In the past 5 years, Pharming's Gross Profit ranged from a high of $38.6 billion in Q1 2021 and a low of -$38.6 billion during Q2 2021
- Over the past 5 years, Pharming's median Gross Profit value was $70.8 million (recorded in 2025), while the average stood at $70.3 million.
- In the last 5 years, Pharming's Gross Profit surged by 16654.71% in 2021 and then tumbled by 7141.7% in 2025.
- Quarter analysis of 5 years shows Pharming's Gross Profit stood at $83.8 million in 2021, then crashed by 42.36% to $48.3 million in 2022, then surged by 53.42% to $74.1 million in 2023, then grew by 8.58% to $80.5 million in 2024, then crashed by 75.83% to $19.4 million in 2025.
- Its Gross Profit was $19.4 million in Q3 2025, compared to $155.0 million in Q2 2025 and $70.8 million in Q1 2025.